Camille L. Bedrosian is VP at Ultragenyx Pharmaceutical Inc. (RARE). They have made 18 open-market trades across 2 companies since 2020, most recently 2026-09-10.
CIK 0001326969
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMLX | 278,064 | $7.3M |
| CRNX | 22,225 | $1.9M |
| RARE | 46,720 | $680K |
| RYTM | 7,000 | $603K |
| Total | $10.5M |
Shares reported on the most recent Form 4, priced at the 2026-09-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMLX | SELL | 2026-09-10 | 2026-09-14 | $32.40 | $325K | -8.7% | -18.2% | — |
| AMLX | SELL | 2026-03-02 | 2026-03-04 | $14.58 | $94K | -3.3% | +6.3% | -10.7% |
| AMLX | SELL | 2025-12-01 | 2025-12-03 | $14.35 | $94K | -10.7% | -18.8% | +0.3% |
| AMLX | SELL | 2025-09-30 | 2025-10-02 | $14.58 | $351K | +4.6% | +0.3% | -10.9% |
| AMLX | SELL | 2025-03-31 | 2025-04-02 | $3.47 | $43K | +10.5% | +50.7% | +81.6% |
| AMLX | SELL | 2024-12-02 | 2024-12-03 | $5.54 | $30K | -23.3% | -27.2% | -44.1% |
| AMLX | SELL | 2024-09-30 | 2024-10-02 | $3.20 | $37K | +18.9% | +87.4% | +25.6% |
| RARE | SELL | 2023-03-01 | 2023-03-03 | $45.25 | $351K | -10.2% | -10.8% | +9.3% |
| RARE | SELL | 2022-03-01 | 2022-03-03 | $66.62 | $376K | +1.0% | +23.9% | -26.8% |
| RARE | SELL | 2022-01-30 | 2022-02-01 | $66.30 | $220K | +1.3% | -10.9% | +0.5% |
| RARE | SELL | 2021-10-14 | 2021-10-18 | $81.14 | $29K | +8.5% | -0.8% | -13.4% |
| RARE | SELL | 2021-09-01 | 2021-09-02 | $100.13 | $751K | -4.1% | -16.0% | -24.7% |
| RARE | SELL | 2021-05-06 | 2021-05-10 | $113.67 | $41K | +7.5% | -9.3% | -13.5% |
| RARE | SELL | 2021-04-15 | 2021-04-19 | $109.09 | $545K | +8.9% | +4.2% | -19.2% |
| RARE | SELL | 2021-03-01 | 2021-03-03 | $138.18 | $1.3M | +3.2% | -9.5% | -20.3% |
| RARE | SELL | 2021-01-30 | 2021-02-02 | $140.36 | $630K | -2.3% | -22.8% | -30.7% |
| RARE | SELL | 2021-01-15 | 2021-01-19 | $139.18 | $3.5M | -0.0% | +3.1% | -24.0% |
| RARE | SELL | 2020-10-14 | 2020-10-16 | $88.00 | $23K | +2.6% | +28.2% | +51.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.